137 related articles for article (PubMed ID: 3324444)
21. Expression of c-myc and c-Ha-ras oncogenes in human lymphoblastoid cells (Namalva).
Mahmoudi M; Motoo Y; Vela GR; Bollon AP; Osther K
Cell Mol Biol; 1989; 35(1):75-80. PubMed ID: 2650877
[TBL] [Abstract][Full Text] [Related]
22. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
Rygaard K; Nakamura T; Spang-Thomsen M
Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
[TBL] [Abstract][Full Text] [Related]
23. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
24. Infrequent ras oncogene point mutations in renal cell carcinoma.
Nanus DM; Mentle IR; Motzer RJ; Bander NH; Albino AP
J Urol; 1990 Jan; 143(1):175-8. PubMed ID: 2403598
[TBL] [Abstract][Full Text] [Related]
25. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
Pfeifer AM; Jones RT; Bowden PE; Mann D; Spillare E; Klein-Szanto AJ; Trump BF; Harris CC
Cancer Res; 1991 Jul; 51(14):3793-801. PubMed ID: 1712250
[TBL] [Abstract][Full Text] [Related]
26. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
Tomita Y; Bilim V; Kawasaki T; Takahashi K; Okan I; Magnusson KP; Wiman KG
Int J Cancer; 1996 May; 66(3):322-5. PubMed ID: 8621251
[TBL] [Abstract][Full Text] [Related]
27. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
28. Expression of cellular oncogenes in teratoma-derived cell lines.
Sejersen T; Sümegi J; Ringertz NR
Exp Cell Res; 1985 Sep; 160(1):19-30. PubMed ID: 2412863
[TBL] [Abstract][Full Text] [Related]
29. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line.
Köhler G; Veelken H; Rosenthal F; Mackensen A; Lindemann A; Schaefer HE; Lahn M
Anticancer Res; 1997; 17(5A):3225-31. PubMed ID: 9413152
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang S; Söderkvist P
Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
32. Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.
McMahon G; Hanson L; Lee JJ; Wogan GN
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9418-22. PubMed ID: 3099282
[TBL] [Abstract][Full Text] [Related]
33. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
34. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
35. Oncogene expression in endocrine pancreatic tumors.
Höfler H; Ruhri C; Pütz B; Wirnsberger G; Hauser H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(6):355-61. PubMed ID: 2904191
[TBL] [Abstract][Full Text] [Related]
36. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
37. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
[TBL] [Abstract][Full Text] [Related]
38. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.
Erisman MD; Scott JK; Astrin SM
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4264-8. PubMed ID: 2542967
[TBL] [Abstract][Full Text] [Related]
39. Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis.
Husain Z; Fei YB; Roy S; Solt DB; Polverini PJ; Biswas DK
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1264-8. PubMed ID: 2493153
[TBL] [Abstract][Full Text] [Related]
40. Oncogene expression of FANFT- or BBN-induced rat urothelial cells.
Debiec-Rychter M; Jones RF; Zukowski K; Wang CY
Int J Cancer; 1990 Nov; 46(5):913-8. PubMed ID: 2228319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
